Navigation Links
Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
Date:9/8/2010

LONDON, Sept. 8 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).  EGFR-RP and VEGFR1 have been demonstrated to play key roles in the underlying causes of various cancers including abnormal angiogenesis and uncontrolled cell division.  Similar to vascular endothelial growth factor receptor 2 (VEGFR2), VEGFR1 also is implicated in the development and progression of age-related macular degeneration (AMD) and other serious ocular diseases.  The EGFR-RP patent is broadly directed to methods of reducing EGFR-RP with a DNA or RNA molecule, including siRNA molecules.  The sequence covered by the VEGFR1 patent is a potent 25mer siRNA, demonstrating Silence's continued ability to secure meaningful intellectual property protection for its portfolio of 25mer sequences.

"The past several months have seen Silence add a number of high-value patents to its broad RNAi intellectual property portfolio.  Whereas many of these recent issuances have focused on the structural modification of RNAi therapeutics to improve efficacy, today's announcement underscores our efforts to concurrently build critical protection in the equally important areas of siRNA sequences and siRNA delivery," said Philip Haworth, Ph.D., chief executive officer of Silence Therapeutics.  "We are particularly pleased that we have been able to secure an additional patent covering 25mer siRNA sequences, validating our belief that we can build a portfolio of proprietary 25mer siRNA sequences that will provide us an added level of protection in the RNAi space.  Furthermore, the breadth of the issued EGFR-RP pa
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Silence Therapeutics and AstraZeneca Extend siRNA Development Collaboration
2. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
3. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
4. Silence Therapeutics Announces Board Changes
5. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
6. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
7. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
8. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
9. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
10. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
11. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (the "Company") (NASDAQ: CLSN ) today announced ... purchase an aggregate of approximately $15 million of the ... led by a dedicated health care fund. ... investors pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
(Date:4/18/2014)... Ky. (April 21, 2014) -- A group of ... Medicine and the Sanders-Brown Center on Aging has ... depression and neuropsychological function in Parkinson,s disease (PD). ... Research , the study, which assessed cognitive function ... that the dopamine replacement therapy commonly used to ...
(Date:4/18/2014)... memories? How did it make you feel? According to ... experience, such as how sad you were or how ... when you can,t stop thinking about it. , ... context of the memories, rather than how you felt, ... the negative effects of these memories, a new study ...
(Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New clues on tissue scarring in scleroderma 2Health News:Study recalculates costs of combination vaccines 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2
... by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial ... School of Medicine, variations of the adiponectin gene, which ... womans risk of developing breast cancer. This discovery is ... it could help experts develop a future genetic testing ...
... NEW YORK (April 25, 2008) -- Heart failure patients ... first to be implanted with the HeartMate II LVAS ... that helps weak hearts pump blood -- that has ... 21 for broad use as bridge to transplantation. As ...
... County Sees Sharp Rise in Gonorrhea Cases, HARRISBURG, Pa., ... of cases of Gonorrhea last year in Delaware County,the Pennsylvania ... of 15 and 24 be routinely screened for the,disease, as ... Gonorrhea grew to 921 in 2007 from 513,the year before., ...
... With an aggressive growth plan in,effect for 2008, YoNaturals ... big step in their expansion efforts with new,vending locations ... of 2006, YoNaturals has maintained a strong,dedication toward changing ... have experienced thus far is in large part due ...
... Winner Renee Zellweger ("Chicago") Reteams with Craig Zadan and Neil Meron, Executive ... Producers for the Sony Pictures Television Project, Based ... a Doctor,s Dramatic Quest to Develop the Lifesaving Breast Cancer ... Drug Herceptin ...
... The Lupus Foundation of,America joins a coalition of approximately ... on May 10. More than 1.5 million,Americans and at ... they struggle daily with the often-debilitating health,consequences of the ... of an unbalanced immune system that can become,destructive to ...
Cached Medicine News:Health News:Study shows gene variations may predict risk of breast cancer in women 2Health News:FDA approves HeartMate II mechanical heart pump for heart-failure patients 2Health News:Gulfport-Biloxi Airport Welcomes Installation of New YoNaturals Healthy Vending Machines 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 2Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 3Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 4Health News:Lifetime Television Proudly Announces October Marquee Event Original Movie, 'Living Proof' Starring Emmy(R) and Grammy(R) Award Winner Harry Connick, Jr. 5Health News:Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People 2
Three-spring evacuator kits with silicone drains, 10 in. hole pattern, trocar and Y-connector tubing...
Provides reliable suction for surgical cases with larger amounts of drainage....
Offers a more constant suction profile than three-spring evacuators, resulting in the potential for improved tissue approximation and reduced risk of hematoma....
Reliavac® 400cc kits with siliconized PVC drain, Y-connector tube...
Medicine Products: